Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Clinical trial NCT07291635 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07291635
- Sponsor
- Aramis Biotechnologies Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-25
- Primary completion
- 2026-10-01
- Enrollment
- 728
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.